Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats

Phytotherapy Research

Volumn 25, Issue 4, 2011, Pages 544-549

  Hasanein, Parisa ^a   Shahidi, Siamak ^b  

^a BU ALI SINA UNIVERSITY   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

diabetes mellitus; Hypericum perforatum; learning; memory; rats

Indexed keywords

GLUCOSE; HYPERICUM PERFORATUM EXTRACT; NOOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; LEARNING DISORDER; LOW DRUG DOSE; MALE; MEMORY DISORDER; NONHUMAN; PASSIVE AVOIDANCE; RAT; STREPTOZOCIN DIABETES;

ANIMALIA; HYPERICUM; HYPERICUM PERFORATUM; RATTUS;

EID: 79953223746     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3298     Document Type: Article

References (45)

1. Amini Z, Boyd B, Doucet J, Ribnicky DM, Stephens JM,. 2009. St John's Wort inhibits adipocyte differentiation and induces insulin resistance in adipocytes. Biochem Biophys Res Commun 388: 146-149.
2. Artola A, Kamal A, Ramakers GM, Biessels GJ, Gispen WH,. 2005. Diabetes mellitus concomitantly facilitates the induction of long-term depression and inhibits that of long-term potentiation in hippocampus. Eur J Neurosci 22: 169-178. (Pubitemid 41059982)
3. Barnes J, Anderson LA, Phillipson JD,. 2001. St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties. J Pharm Pharmacol 53: 583-600. (Pubitemid 32457809)
4. Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR,. 2000. Drug interaction between St John's wort and cyclosporine. Ann Pharmacother 34: 1013-1016. (Pubitemid 30660777)
5. Baydas G, Nedzvetskii VS, Nerush PA, Kirichenko SV, Yoldas T,. 2003. Altered expression of NCAM in hippocampus and cortex may underlie memory and learning deficits in rats with streptozotocin-induced diabetes mellitus. Life Sci 73: 1907-1916. (Pubitemid 36934505)
6. Baynes JW,. 1991. Role of oxidative stress in development of complications in diabetes. Diabetes 40: 405-412.
7. Beijamini V, Andreatini R,. 2003. Effects of Hypericum perforatum and paroxetine on rat performance in the elevated T-maze. Pharmacol Res 48: 199-207. (Pubitemid 36683169)
8. Bolley R, Zülke C, Kammerl M, Fischereder M, Kramer BK,. 2002. Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. Transplantation 27: 100.
9. Breidenbach H, Hoffmann MW, Becker T, Schlitt H, Klempnauer J,. 2000. Drug interaction of St John's wort with cyclosporin. Lancet 355: 1912. (Pubitemid 30311894)
10. Craig WJ,. 1999. Health-promoting properties of common herbs. Am J Clin Nutr 70: S491-S499.
11. de Maat MM, Hoetelmans RM, Math t RA, et al. 1999. Drug interaction between St John's wort and nevirapine. AIDS 15: 420-412.
12. Dimpfel W, Todorova A, Vonderheid-Guth B,. 1999. Pharmacodynamic properties of St John's Wort-A single blind neurophysiological study in healthy subjects comparing two commercial preparations. Eur J Med Res 4: 303-312.
13. El-Sherbiny DA, Khalifa AE, Attia AS, Eldenshary EE,. 2003. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 76: 525-533. (Pubitemid 37487909)
14. Feily A, Abbasi N,. 2009. The inhibitory effect of Hypericum perforatum extract on morphine withdrawal syndrome in rat and comparison with clonidine. Phytother Res 23: 1549-1552.
15. Gispen WH, Biessels GJ,. 2000. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 23: 542-549.
16. Hemeryck A, Belpaire FM,. 2002. Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update. Curr Drug Metab 3: 13-37. (Pubitemid 34296308)
17. Hunt EJ, Lester CE, Lester EA, Tackett RL,. 2001. Effect of St John's wort on free radical production. Life Sci 69: 181-190. (Pubitemid 32523074)
18. Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A,. 1994. Effects of hypericum extract LI 160 compared with maprotiline on resting EEG and evoked potentials in 24 volunteers. J Geriatr Psychiatry Neurol 7: S44-S46. (Pubitemid 24330531)
19. Kakkar R, Kalra J, Mantha S, Prasad K,. 1995. Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119.
20. Khalifa AE,. 2001. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice. J Ethnopharmacol 76: 49-57. (Pubitemid 32510730)
21. Kim JY, van de WE, Laplante M, et al. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637. (Pubitemid 47494363)
22. Klusa V, Germane S, Nöldner M, Chatterjee SS,. 2001. Hypericum extract and hyperforin: memory-enhancing properties in rodents. Pharmacopsychiatry 34: S61-S69.
23. Kucukatay V, Aǧar A, Gumuslu S, Yargiçoǧlu P,. 2007. Effect of sulfur dioxide on active and passive avoidance in experimental diabetes mellitus: relation to oxidant stress and antioxidant enzymes. Int J Neurosci 117: 1091-1107. (Pubitemid 47026890)
24. Kulkarni SK, Joseph P,. 1998. Psychopharmacological profile of siotone granules, a herbal preparation. Indian Drugs 35: 536-544. (Pubitemid 28454752)
25. Kumar V, Singh PN, Muruganandam AV, Bhattacharya SK,. 2000. Effect of Indian Hypericum perforatum Linn on animal models of cognitive dysfunction. J Ethnopharmacol 72: 119-128.
26. Lashgari R, Motamedi F, Zahedi Asl S, Shahidi S, Komaki A,. 2006. Behavioral and electrophysiological studies of chronic oral administration of L-type calcium channel blocker verapamil on learning and memory in rats. Behav Brain Res 171: 324-328. (Pubitemid 43946507)
27. Lupien SB, Bluhm EJ, Ishii DN,. 2003. Systemic insulin-like growth factor-I administration prevents cognitive impairment in diabetic rats, and brain IGF regulates learning/memory in normal adult rats. J Neurosci Res 74: 512-523. (Pubitemid 37352073)
28. McCall AL,. 1992. The impact of diabetes on the CNS. Diabetes 41: 557-570.
29. Misane I, Ogren SO,. 2001. Effects of Hypericum perforatum (St John's wort) on passive avoidance in the rat: evaluation of potential neurochemical mechanisms underlying its antidepressant activity. Pharmacopsychiatry 34: S89-S97. (Pubitemid 32701746)
30. Moschella C, Jaber BL,. 2001. Interaction between cyclosporine and Hypericum perforatum (St. John's wort) after organ transplantation. Am J Kidney Dis 38: 1105-1107. (Pubitemid 33022190)
31. Patil CS, Singh VP, Kulkarni SK,. 2006. Modulatory effect of sildenafil in diabetes and electroconvulsive shock-induced cognitive dysfunction in rats. Pharmacol Rep 58: 373-380. (Pubitemid 44111072)
32. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J,. 2000. Indinavir concentrations and St John's wort. Lancet 355: 547-548. (Pubitemid 30088677)
33. Reaven GM, Thompson LW, Nahum D, Haskins E,. 1990. Relationship between hyperglycemia and cognitive function in older NIDDM patients. Diabetes Care 13: 16-21. (Pubitemid 20024725)
34. Ryan CM,. 1988. Neurobehavioral complications of type I diabetes. Examination of possible risk factors. Diabetes Care 11: 86-93.
35. Ryan EA, Pick ME, Marceau C,. 2001. Use of alternative medicines in diabetes mellitus. Diabet Med 18: 242-245. (Pubitemid 32397864)
36. Shahidi S, Komaki A, Mahmoodi M, Atrvash N, Ghodrati M,. 2008. Ascorbic acid supplementation could affect passive avoidance learning and memory in rat. Brain Res Bull 76: 109-113.
37. Shahidi S, Motamedi F, Bakeshloo SA, Taleghani BK,. 2004. The effect of reversible inactivation of the supramammillary nucleus on passive avoidance learning in rats. Behav Brain Res 152: 81-87. (Pubitemid 38597066)
38. Singh A, Naidu PS, Gupta S, Kulkarni SK,. 2002. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. J Med Food 5: 211-220. (Pubitemid 36331634)
39. Tiwari V, Kuhad A, Bishnoi M, Chopra K,. 2009. Chronic treatment with tocotrienol, an isoform of vitamin E, prevents intracerebroventricular streptozotocin-induced cognitive impairment and oxidative-nitrosative stress in rats. Pharmacol Biochem Behav 93: 183-189.
40. Tun PA, Nathan DM, Perlmuter LC,. 1990. Cognitive and affective disorders in elderly diabetics. Clin Geriatr Med 6: 731-746. (Pubitemid 20381239)
41. Tuzcu M, Baydas G,. 2006. Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats. Eur J Pharmacol 537: 106-110.
42. Vitiello B,. 1999. Hypericum perforatum extracts as potential antidepressants. J Pharm Pharmacol 51: 513-517. (Pubitemid 29319775)
43. Wang MY, Grayburn P, Chen S, Ravazzola M, Orci L, Unger RH,. 2008. Adipogenic capacity and the susceptibility to type 2 diabetes and metabolic syndrome. Proc Natl Acad Sci USA 105: 6139-6144. (Pubitemid 351758412)
44. Widy-Tyszkiewicz E, Piechal A, Joniec I, Blecharz-Klin K,. 2002. Long term administration of Hypericum perforatum improves spatial learning and memory in the water maze. Biol Pharm Bull 25: 1289-1294. (Pubitemid 39663187)
45. Xu H, Williams KM, Liauw WS, Murray M, Day RO, McLachlan AJ,. 2008. Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide. Br J Pharmacol 153: 1579-1586. (Pubitemid 351481511)